1. Home
  2. ERIC vs NTRA Comparison

ERIC vs NTRA Comparison

Compare ERIC & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ericsson

ERIC

Ericsson

HOLD

Current Price

$9.62

Market Cap

32.1B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$225.16

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERIC
NTRA
Founded
1876
2003
Country
Sweden
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.1B
27.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ERIC
NTRA
Price
$9.62
$225.16
Analyst Decision
Hold
Strong Buy
Analyst Count
1
15
Target Price
$9.80
$235.87
AVG Volume (30 Days)
8.6M
1.5M
Earning Date
01-23-2026
11-06-2025
Dividend Yield
2.04%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$25,502,929,121.00
$2,116,676,000.00
Revenue This Year
N/A
$32.77
Revenue Next Year
N/A
$16.51
P/E Ratio
$12.30
N/A
Revenue Growth
N/A
38.17
52 Week Low
$6.64
$125.38
52 Week High
$10.35
$246.90

Technical Indicators

Market Signals
Indicator
ERIC
NTRA
Relative Strength Index (RSI) 52.51 52.07
Support Level $9.54 $221.84
Resistance Level $9.68 $232.76
Average True Range (ATR) 0.12 6.19
MACD -0.01 -3.10
Stochastic Oscillator 40.32 16.96

Price Performance

Historical Comparison
ERIC
NTRA

About ERIC Ericsson

Ericsson provides telecom equipment and services that are primarily used to build and operate mobile networks. The firm divides its business into three segments: networks, cloud and software services, and enterprise. Wireless carriers have traditionally been the firm's primary customers, but it is pushing to cater more to enterprises as well, as both try to take advantage of 5G capabilities and utilize "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: